Decoy Biosystems
San Diego
About Decoy Biosystems
Decoy Biosystems is a biotechnology company developing a novel and potentially best in class, multiple Toll-like receptor (TLR) agonist-based cancer immunotherapy. Decoy is dedicated to enhancing the expanding curative cancer immunology for patients with unresectable or metastatic solid tumors and lymphomas, which are responsible for approximately 90 percent of all cancer deaths.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $6.0M
- Funding stage: M&A
- Last round: Seed (Oct 2018)
- Website: decoybio.com
- Phone: 858-492-0485
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/decoy-biosystems-130778 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.